Royal Melbourne Hospital, Melbourne, VIC, Australia.
Med J Aust. 2011 Feb 7;194(3):121-5. doi: 10.5694/j.1326-5377.2011.tb03796.x.
To examine the adequacy of policies at Australian medical schools for managing potential conflicts of interest with the pharmaceutical industry.
DESIGN, SETTING AND PARTICIPANTS: National survey of 20 Australian medical schools to assess their policies regarding disclosure and management of conflict of interest, undertaken in October 2009, using the American Medical Student Association's PharmFree Scorecard.
Policy scores and grades for Australian medical schools.
Compared with United States medical schools, Australian medical schools performed better in only the curriculum domain and had a lower mean score overall (44% v 58%; P < 0.001).
Our results indicate a need for improved self-regulation of conflicts of interest in Australian medical schools.
考察澳大利亚医学院校处理与制药业潜在利益冲突的政策是否充分。
设计、地点和参与者：2009 年 10 月，对澳大利亚 20 所医学院校进行了全国性调查，使用美国医学生协会的 PharmFree 记分卡评估其关于披露和管理利益冲突的政策。
澳大利亚医学院校的政策得分和等级。
与美国医学院校相比，澳大利亚医学院校仅在课程领域表现较好，总体平均得分较低（44%比 58%；P<0.001）。
我们的结果表明，澳大利亚医学院校需要加强自我监管，以处理利益冲突问题。
